Cardiology

In the SOLOIST-WHF trial, risk for HF readmission and CV death were reduced by more than 50% at 30- and 90-days after hospital discharge.

AHA 2022: Chronic users of either e-cigarettes or traditional cigarettes had acute changes in cardiovascular function and performed worse on exercise stress testing than never users in new study.

Apixaban was associated with up to a 28% lower risk of GI bleeding vs the 3 other direct oral anticoagulants in the first large-scale comparative analysis.

ObesityWeek® 2022. Primary care clinicians report providing on average just 70% of a wide range of clinical weight management services, according to a new survey.

AHA 2022: An estimated 18% of Americans with heart disease reported using wearables, compared with 29% of the total US population.

AHA 2022. A perception of discrimination was associated with worse mental health and disease-related health status 1 year post-MI among adults aged ≤55 years.

Use of telemedicine and home blood pressure monitoring may mitigate adverse impact on BP control during future large-scale emergencies, noted researchers.

Black patients were also at significantly increased risk of stroke, bleeding, and mortality vs White patients 1 year following discharge.

The findings underscore the importance of routine eGFR and UACR screening in primary care to ensure early detection of CKD and avoid related adverse outcomes.

To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.

CMHC 2022: Patients with NASH are often not diagnosed until an advanced stage, and have a high burden of comorbidities, according to new study.

Your daily dose of the clinical news you may have missed.

CMHC. PCPs and cardiologists appeared to perform only half of items considered necessary for care of T2D patients in a new simulated patient study.

CMHC 2022: A decrease in vitamin D levels is associated with increased cardiovascular risk in patients with type 2 diabetes, according to new study.

In the absence of randomized controlled head-to-head trials comparing the 2 anticoagulants, study authors say clinicians should consider their findings when choosing treatment.

Your daily dose of clinical news from Patient Care Online.

Findings underscore the need for ongoing efforts to improve prevention strategies, as CVD risk factors in younger women continue to rise, according to authors.

Your daily dose of clinical news from Patient Care Online.

Smoking, age, diabetes, race/ethnicity, and BMI may all pose a greater risk for mortality in severe COVID-19 infection than preexisting CVD, study suggests.

Studies of cardiometabolic disease pathophysiology, prevention, and treatment make science news every day. Find 12 here, at-a-glance.

Novel NMDA receptor antagonist approved for the treatment of major depressive disorder, first topical PDE4i approved for plaque psoriasis, and more.

When modeled as first-line therapy vs metformin, treatment benefit was significantly outweighed by cost for both classes.

The rate of food insecurity among persons with CVD nearly doubled over 20 years, according to new research.

Dr Maruthur, a primary care physician, helped develop the new ADA/EASD consensus report on T2D management and has suggestions.

A T2D diagnosis in adults aged 50 to 59 years vs 60 to 69 years or ≥70 years was linked to significantly increased risk for cardio- and cerebrovascular disease and all-cause mortality.

Dr Maruthur, of Johns Hopkins Medicine, talks about how the concept of "holistic" patient care continues to expand in the management of persons with T2D.

Only 1 lot of each medication was affected by the mislabeling, according to generic repackaging and distribution services company Golden State Medical Supply.

Multimorbidity was associated with a 63% increased risk for dementia among adults older than age 60 years followed for up to 15 years.

Obstructive sleep apnea is a cause of secondary hypertension in up to 50% of cases; more common causes here, from the 2017 ACC/AHA hypertension guidelines.

SGLT-2 inhibitors and drugs to treat HFrEF were compared for efficacy in patients with HF with LVEF ≥40%.